EEF1G

Elongation factor 1-gamma · P26641 · EEF1G on Sugi Atlas →

0 patent compounds predicted against EEF1G, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to EEF1G by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Everolimus for Children With Recurrent or Progressive Ependymoma PHASE2COMPLETED
A Study of Bezafibrate in Mitochondrial Myopathy PHASE2COMPLETED
Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients PHASE1/PHASE2COMPLETED
Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients PHASE2COMPLETED
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS PHASE2COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Cixutumumab and Temsirolimus in Treating Younger Patients With Solid Tumors That Have Recurred or Not Responded to Treatment PHASE1COMPLETED
Evaluation of the Safety and the Tolerability of a Combination of Two HIV Inducers in Patients With Undetectable Viral Load PHASE1COMPLETED
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors nanCOMPLETED
Effect of Branched Chain Amino Acids on Muscle nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Role of Amino Acids and Genetic Disorder in Pathogenesis of Heart Failure nanUNKNOWN
Quantification of GADD34 Expression in RA nanCOMPLETED
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study) nanRECRUITING
Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML) nanCOMPLETED
Study of Biomarkers in Tissue Samples From Patients With Breast Cancer nanUNKNOWN
Recombinant Interferon Alfa-2b in Treating Patients With Melanoma nanCOMPLETED
Research on the Early and Prognosis Diagnosis of Vascular Dementia nanRECRUITING
Investigating the Genetic Basis of Pseudoexfoliation Syndrome, Angle-closure Glaucoma and Primary Open-angle Glaucoma nanRECRUITING
EKLF Gene Expression in β-thalassemia nanNOT_YET_RECRUITING
NCF Gene & TNFSF4 in SLE Patients nanUNKNOWN
Anesthetic Methods and Gene Expression Profile nanCOMPLETED
Study of Tissue Samples in Predicting How Well Chemotherapy and Radiation Therapy Will Kill Cancer Cells in Patients With Squamous Cell Carcinoma of the Esophagus nanUNKNOWN
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics nanUNKNOWN
Mitochondrial Activity and Myosteatosis in the Cachexia of Cancers of the Upper Aerodigestive Tract nanUNKNOWN
Transcriptomic Profile of Patients Treated With Different Modalities of Spinal Cord Stimulation nanUNKNOWN
miR-155 Expression in Episodic and Chronic Migraine nanUNKNOWN
MEHMO Natural History and Biomarkers nanRECRUITING
Autophagy Bladder Cancer nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a EEF1G binder may also engage these)

ProteinNameSimilarity
Q9D8N0 1.000 Q9D8N0 →
A2Q127 1.000 A2Q127 →
Q3SZV3 1.000 Q3SZV3 →
P29694 1.000 P29694 →
Q68FR6 1.000 Q68FR6 →
Q4R7H5 1.000 Q4R7H5 →
Q29387 1.000 Q29387 →
Q90YC0 0.997 Q90YC0 →
P26642 0.996 P26642 →
Q91375 0.992 Q91375 →
Q6PE25 0.991 Q6PE25 →
Q9ZRI7 0.987 Q9ZRI7 →
P12261 0.986 P12261 →
O04487 0.984 O04487 →
Q6YW46 0.984 Q6YW46 →
Q7PZD5 0.983 Q7PZD5 →
P36008 0.982 P36008 →
A0A1U8QXK4 0.982 A0A1U8QXK4 →
P54412 0.982 P54412 →
Q9FUM1 0.982 Q9FUM1 →
Q7SH49 0.982 Q7SH49 →
P40921 0.981 P40921 →
Q9FVT2 0.981 Q9FVT2 →
Q0II26 0.981 Q0II26 →
Q9NJH0 0.981 Q9NJH0 →
Q8BX57 0.981 Q8BX57 →
Q5Z627 0.981 Q5Z627 →
Q32PX2 0.980 Q32PX2 →
Q27974 0.980 Q27974 →
Q5EU90 0.980 Q5EU90 →